ArticleFrontiers in oncology2026

ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.

Pedro Gonzalez Santa-Catalina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.